Clinical improvement following treatment at the INR in Los Angeles is documented, eight years after stroke. For further information regarding additional patients please see Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. Edward Tobinick MD. CNS Drugs. 2011 Feb;25(2):145-155.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional treatment doses may be necessary to maintain the clinical response. Treatment for this indication is off-label. Please see the Terms of Use. The method of treatment utilized is a patented invention of the INR. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. patents 6419944, 6537549, 6982089, 7214658, 76929311, 8119127, 8236306, 8349323 and 8900583 all assigned to TACT IP, LLC; and Australian patent 758523.